Global Castleman Disease Treatment Market Size, Status and Forecast 2019-2025

2019-01-14 / 3900.00 / Pharma & Healthcare / 91 Pages

Description

Castleman disease is a rare condition of lymph nodes and similar tissues. This condition occurs when too many non-cancer cells started to grow in the lymph node. After initial growth hard growth started to form. Usually, it occurs in the chest, abdomen or neck. This condition is also called as angiofollicular lymph node hyperplasia. There are no known risk factors for castleman disease, but it usually occur in adults with weakened immune system.
The factor driving the growth of the castleman disease market is the life style. In today's time, immune system of people is getting weaker due to various life style conditions. Increasing prevalence of AIDS is also driving the growth of castleman disease treatment market. Government support for the development of orphan drugs and allowing premium pricing of these drugs will be helpful in generating high revenue for companies. High unmet need also expected to drive the growth of castleman disease treatment market.
In 2018, the global Castleman Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Castleman Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Castleman Disease Treatment development in United States, Europe and China.

The key players covered in this study
Johnson & Johnson
F.Hoffmann-La Roche
Bristol-Myers Squibb
Merck
Pfizer
Hospira
Incyte
Novartis

Market segment by Type, the product can be split into
Monoclonal Antibodies
Chemotherapy
Radiation Therapy
Immunotherapy
Corticosteroids
Antiviral Drugs 

Market segment by Application, split into
Hospitals
Clinical
Ambulatory Care Units

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Castleman Disease Treatment status, future forecast, growth opportunity, key market and key players.
To present the Castleman Disease Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Castleman Disease Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Content

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Castleman Disease Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Monoclonal Antibodies
1.4.3 Chemotherapy
1.4.4 Radiation Therapy
1.4.5 Immunotherapy
1.4.6 Corticosteroids
1.4.7 Antiviral Drugs 
1.5 Market by Application
1.5.1 Global Castleman Disease Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinical
1.5.4 Ambulatory Care Units
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Castleman Disease Treatment Market Size
2.2 Castleman Disease Treatment Growth Trends by Regions
2.2.1 Castleman Disease Treatment Market Size by Regions (2014-2025)
2.2.2 Castleman Disease Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Castleman Disease Treatment Market Size by Manufacturers
3.1.1 Global Castleman Disease Treatment Revenue by Manufacturers (2014-2018)
3.1.2 Global Castleman Disease Treatment Revenue Market Share by Manufacturers (2014-2018)
3.1.3 Global Castleman Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Castleman Disease Treatment Key Players Head office and Area Served
3.3 Key Players Castleman Disease Treatment Product/Solution/Service
3.4 Date of Enter into Castleman Disease Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Castleman Disease Treatment Market Size by Type (2014-2019)
4.2 Global Castleman Disease Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Castleman Disease Treatment Market Size (2014-2019)
5.2 Castleman Disease Treatment Key Players in United States
5.3 United States Castleman Disease Treatment Market Size by Type
5.4 United States Castleman Disease Treatment Market Size by Application

6 Europe
6.1 Europe Castleman Disease Treatment Market Size (2014-2019)
6.2 Castleman Disease Treatment Key Players in Europe
6.3 Europe Castleman Disease Treatment Market Size by Type
6.4 Europe Castleman Disease Treatment Market Size by Application

7 China
7.1 China Castleman Disease Treatment Market Size (2014-2019)
7.2 Castleman Disease Treatment Key Players in China
7.3 China Castleman Disease Treatment Market Size by Type
7.4 China Castleman Disease Treatment Market Size by Application

8 Japan
8.1 Japan Castleman Disease Treatment Market Size (2014-2019)
8.2 Castleman Disease Treatment Key Players in Japan
8.3 Japan Castleman Disease Treatment Market Size by Type
8.4 Japan Castleman Disease Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Castleman Disease Treatment Market Size (2014-2019)
9.2 Castleman Disease Treatment Key Players in Southeast Asia
9.3 Southeast Asia Castleman Disease Treatment Market Size by Type
9.4 Southeast Asia Castleman Disease Treatment Market Size by Application

10 India
10.1 India Castleman Disease Treatment Market Size (2014-2019)
10.2 Castleman Disease Treatment Key Players in India
10.3 India Castleman Disease Treatment Market Size by Type
10.4 India Castleman Disease Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Castleman Disease Treatment Market Size (2014-2019)
11.2 Castleman Disease Treatment Key Players in Central & South America
11.3 Central & South America Castleman Disease Treatment Market Size by Type
11.4 Central & South America Castleman Disease Treatment Market Size by Application

12 International Players Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Company Details
12.1.2 Company Description and Business Overview
12.1.3 Castleman Disease Treatment Introduction
12.1.4 Johnson & Johnson Revenue in Castleman Disease Treatment Business (2014-2019)
12.1.5 Johnson & Johnson Recent Development
12.2 F.Hoffmann-La Roche
12.2.1 F.Hoffmann-La Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Castleman Disease Treatment Introduction
12.2.4 F.Hoffmann-La Roche Revenue in Castleman Disease Treatment Business (2014-2019)
12.2.5 F.Hoffmann-La Roche Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Castleman Disease Treatment Introduction
12.3.4 Bristol-Myers Squibb Revenue in Castleman Disease Treatment Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Castleman Disease Treatment Introduction
12.4.4 Merck Revenue in Castleman Disease Treatment Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Castleman Disease Treatment Introduction
12.5.4 Pfizer Revenue in Castleman Disease Treatment Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Hospira
12.6.1 Hospira Company Details
12.6.2 Company Description and Business Overview
12.6.3 Castleman Disease Treatment Introduction
12.6.4 Hospira Revenue in Castleman Disease Treatment Business (2014-2019)
12.6.5 Hospira Recent Development
12.7 Incyte
12.7.1 Incyte Company Details
12.7.2 Company Description and Business Overview
12.7.3 Castleman Disease Treatment Introduction
12.7.4 Incyte Revenue in Castleman Disease Treatment Business (2014-2019)
12.7.5 Incyte Recent Development
12.8 Novartis
12.8.1 Novartis Company Details
12.8.2 Company Description and Business Overview
12.8.3 Castleman Disease Treatment Introduction
12.8.4 Novartis Revenue in Castleman Disease Treatment Business (2014-2019)
12.8.5 Novartis Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details


Table of Figures

List of Tables and Figures

Table Castleman Disease Treatment Key Market Segments
Table Key Players Castleman Disease Treatment Covered
Table Global Castleman Disease Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Castleman Disease Treatment Market Size Market Share by Type 2014-2025
Figure Monoclonal Antibodies Figures
Table Key Players of Monoclonal Antibodies
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Immunotherapy Figures
Table Key Players of Immunotherapy
Figure Corticosteroids Figures
Table Key Players of Corticosteroids
Figure Antiviral Drugs  Figures
Table Key Players of Antiviral Drugs 
Table Global Castleman Disease Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinical Case Studies
Figure Ambulatory Care Units Case Studies
Figure Castleman Disease Treatment Report Years Considered
Table Global Castleman Disease Treatment Market Size 2014-2025 (Million US$)
Figure Global Castleman Disease Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Castleman Disease Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Castleman Disease Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Castleman Disease Treatment Market Share by Regions 2014-2019
Figure Global Castleman Disease Treatment Market Share by Regions 2014-2019
Figure Global Castleman Disease Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Castleman Disease Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Castleman Disease Treatment Market Share by Manufacturers (2014-2019)
Figure Global Castleman Disease Treatment Market Share by Manufacturers in 2018
Table Global Castleman Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Castleman Disease Treatment Product/Solution/Service
Table Date of Enter into Castleman Disease Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Castleman Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Castleman Disease Treatment Market Size Share by Type (2014-2019)
Figure Global Castleman Disease Treatment Market Size Market Share by Type (2014-2019)
Table Global Castleman Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Castleman Disease Treatment Market Size Share by Application (2014-2019)
Figure Global Castleman Disease Treatment Market Size Market Share by Application (2014-2019)
Figure Global Castleman Disease Treatment Revenue Market Share by Application in 2018
Figure United States Castleman Disease Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Castleman Disease Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Castleman Disease Treatment Market Share (2018-2019)
Table United States Castleman Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Castleman Disease Treatment Market Share by Type (2014-2019)
Table United States Castleman Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Castleman Disease Treatment Market Share by Application (2014-2019)
Figure Europe Castleman Disease Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Castleman Disease Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Castleman Disease Treatment Market Share (2018-2019)
Table Europe Castleman Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Castleman Disease Treatment Market Share by Type (2014-2019)
Table Europe Castleman Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Castleman Disease Treatment Market Share by Application (2014-2019)
Figure China Castleman Disease Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Castleman Disease Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Castleman Disease Treatment Market Share (2018-2019)
Table China Castleman Disease Treatment Market Size by Type (2014-20189) (Million US$)
Table China Castleman Disease Treatment Market Share by Type (2014-2019)
Table China Castleman Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table China Castleman Disease Treatment Market Share by Application (2014-2019)
Figure Japan Castleman Disease Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Castleman Disease Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Castleman Disease Treatment Market Share (2018-2019)
Table Japan Castleman Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Castleman Disease Treatment Market Share by Type (2014-2019)
Table Japan Castleman Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Castleman Disease Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Castleman Disease Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Castleman Disease Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Castleman Disease Treatment Market Share (2018-2019)
Table Southeast Asia Castleman Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Castleman Disease Treatment Market Share by Type (2014-2019)
Table Southeast Asia Castleman Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Castleman Disease Treatment Market Share by Application (2014-2019)
Figure India Castleman Disease Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Castleman Disease Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Castleman Disease Treatment Market Share (2018-2019)
Table India Castleman Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table India Castleman Disease Treatment Market Share by Type (2014-2019)
Table India Castleman Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table India Castleman Disease Treatment Market Share by Application (2014-2019)
Figure Central & South America Castleman Disease Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Castleman Disease Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Castleman Disease Treatment Market Share (2018-2019)
Table Central & South America Castleman Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Castleman Disease Treatment Market Share by Type (2014-2019)
Table Central & South America Castleman Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Castleman Disease Treatment Market Share by Application (2014-2019)
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Castleman Disease Treatment Business (2014-2019) (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Castleman Disease Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table F.Hoffmann-La Roche Company Details
Table F.Hoffmann-La Roche Revenue in Castleman Disease Treatment Business (2014-2019)(Million US$)
Figure F.Hoffmann-La Roche Revenue Growth Rate in Castleman Disease Treatment Business (2014-2019)
Table F.Hoffmann-La Roche Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Castleman Disease Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Castleman Disease Treatment Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Merck Company Details
Table Merck Revenue in Castleman Disease Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Castleman Disease Treatment Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Castleman Disease Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Castleman Disease Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Hospira Company Details
Table Hospira Revenue in Castleman Disease Treatment Business (2014-2019)(Million US$)
Figure Hospira Revenue Growth Rate in Castleman Disease Treatment Business (2014-2019)
Table Hospira Recent Development
Table Incyte Company Details
Table Incyte Revenue in Castleman Disease Treatment Business (2014-2019)(Million US$)
Figure Incyte Revenue Growth Rate in Castleman Disease Treatment Business (2014-2019)
Table Incyte Recent Development
Table Novartis Company Details
Table Novartis Revenue in Castleman Disease Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Castleman Disease Treatment Business (2014-2019)
Table Novartis Recent Development
Table Global Castleman Disease Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Castleman Disease Treatment Market Size Share by Regions (2019-2025)
Figure Global Castleman Disease Treatment Market Size Share by Regions in 2025
Figure United States Castleman Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Castleman Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Castleman Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Castleman Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Castleman Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Castleman Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Castleman Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Castleman Disease Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Castleman Disease Treatment Market Size by Product (2019-2025)
Figure Global Castleman Disease Treatment Market Size by Product in 2025
Table Global Castleman Disease Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Castleman Disease Treatment Market Size by Application (2019-2025)
Figure Global Castleman Disease Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

* mark fields are compulsory